<h4>Background</h4>The glucagon-like peptide-1 receptor (GLP-1R) agonist liraglutide is an effective therapeutic agent for obesity, primarily through its ability to suppress appetite and delay gastric emptying. The gene discussed is GLP1R; the disease is obesity disorder.